Maurice Browning This is Me
View Title...
Bowman Gray School of Medicine
Winston-Salem, North Carolina
Please Note:
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 1 reference found on the Internet. This information has not been verified. Learn more...
Employment History
View...Web References
-
1. www.odysseyresearch.org
www.odysseyresearch.org/mauric - [Cached]Published on: 2/7/2001 Last Visited: 2/7/2001
Maurice Browning Regional Manager Since 1968
...
Maurice Browning Maurice Browning Maurice Browning Maurice Browning has been involved in biomedical and clinical research since the late 60's. From 1968 through 1977, he held several senior positions at the National Institutes of Health. From 1972 - 1977, Maurice managed the extramural research grants program at the National Cancer Institute.
Upon leaving NIH in 1977, Maurice was appointed the Administrative Director of the Oncology Research Center at Bowman Gray School of Medicine in Winston-Salem, North Carolina. In that position, he was responsible for the Center's clinical research programs. To access more patients, he established collaborative sites in West Virginia, Southwest Virginia, Western North Carolina and Eastern Tennessee and in Northwest South Carolina. During his tenure at Bowman Gray, clinical cancer research expanded over 400 %, and the Oncology Research Center became one of the major patient enrollment centers in new protocols from industry and the NCI.
In 1980, he joined the emerging J. Graham Brown Cancer Center in Louisville, Kentucky. This facility, the idea of a number of prominent Kentuckians in and around Louisville, was privately developed and then donated to the University of Louisville with the understanding that the University would man it and take responsibility for the research programs, both clinical and basic, conducted in the Center. Maurice had the responsibility for initiating the research programs and assisted in the hiring of the initial investigator team.
In 1982, Maurice moved to Bar Harbor, Maine to become Director of Sponsored Research at The Jackson Laboratory. During the 8 years he was there, the basic research programs of The Laboratory increased 4 fold. The Laboratory initiated a program, with funding from the Howard Hughes Medical Foundation, and in collaboration with The Johns Hopkins University, to begin the mapping of the mouse genome. This effort resulted in the naming of The Jackson Laboratory as a national center for genomic research by the National Institutes of Health.
In 1988 Maurice moved to Montana to help in the recreation of the McLaughlin Research Institute. He managed a campaign that was successful in obtaining funding from the State of Montana, the Congress, City of Great Falls and the Sisters of Charity along with several private donors to build a state-of-the-art facility doing molecular genetic research on a number of diseases including cancer, Alzheimer's disease, and diabetes. The work done in this facility, in collaboration with Doctor Stan Prusiner of the University of California, resulted in the recent award of the Nobel Prize in Medicine to Doctor Prusiner for his work on prion disease.
In 1990, Maurice made another career shift and joined the staff of the fledgling Deaconess Research Institute in Billings. During his tenure with DRI, he moved the organization to new quarters, initiated a number of highly successful clinical research projects and managed the Ibandronate studies.
Those studies, investigating a compound for the treatment of osteoporosis, were highly successful. Operated at 32 sites throughout Montana, Wyoming, the Dakotas and portions of Nebraska and Iowa, nearly 1, 000 women were recruited to participate in these studies. Collectively the DRI sites enrolled more patients into these studies than any other site in the US and DRI was the number 2 enrollment site in the world for these studies.
The success of these studies and the unique way in which enrollment was handled at the smaller sites has been the subject of several journal articles that Maurice has co-authored with Charles H. Chesnut III, MD of the Osteoporosis Research Group in Seattle.
Since 1997, Maurice has been involved in assisting both CareTrends Health Education and Research Institute in Sioux Falls and The Sheridan Research Institute develop their clinical research programs. As a member of the Odyssey Research team, Maurice will be generating significant patient enrollment in Odyssey Research managed studies in eastern Washington, Montana, Wyoming and portions of Nebraska.
Return to the About Us page.

